Fundraising Fox
Recludix
San Diego, US · 54 employees on LinkedIn · 3 known investors
Find your way into Recludix
Sign up to find every way you can get introduced to Recludix
- Your email: who you already know at Recludix, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Recludix team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Recludix Pharma operates a drug discovery platform that combines custom DNA-encoded libraries (DELs), massively parallel structure-activity relationship analysis, structure-based design, and a family-wide SH2 domain screening panel. It applies this approach first to discover selective SH2 domain inhibitors for treating inflammatory diseases.
Founders & leadership
Investors · 3
In the news
Frequently asked questions
- What does Recludix do?
- Recludix Pharma operates a drug discovery platform that combines custom DNA-encoded libraries (DELs), massively parallel structure-activity relationship analysis, structure-based design, and a family-wide SH2 domain screening panel. It applies this approach first to discover selective SH2 domain inhibitors for treating inflammatory diseases.
- Who are Recludix's investors?
- Recludix's investors include Access Biotechnology, New Enterprise Associates (NEA), Westlake Village BioPartners.
- Where is Recludix headquartered?
- Recludix is headquartered in San Diego, US.